KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Pension (2016 - 2025)

Abbott Laboratories' Pension history spans 16 years, with the latest figure at $7.6 billion for Q4 2025.

  • For Q4 2025, Pension rose 12.17% year-over-year to $7.6 billion; the TTM value through Dec 2025 reached $7.6 billion, up 12.17%, while the annual FY2025 figure was $7.6 billion, 12.17% up from the prior year.
  • Pension for Q4 2025 was $7.6 billion at Abbott Laboratories, up from $6.7 billion in the prior quarter.
  • Across five years, Pension topped out at $9.1 billion in Q2 2021 and bottomed at $6.6 billion in Q2 2024.
  • The 5-year median for Pension is $7.2 billion (2023), against an average of $7.6 billion.
  • The largest annual shift saw Pension fell 16.69% in 2023 before it increased 12.17% in 2025.
  • A 5-year view of Pension shows it stood at $8.8 billion in 2021, then dropped by 14.24% to $7.5 billion in 2022, then dropped by 7.64% to $6.9 billion in 2023, then decreased by 3.11% to $6.7 billion in 2024, then rose by 12.17% to $7.6 billion in 2025.
  • Per Business Quant, the three most recent readings for ABT's Pension are $7.6 billion (Q4 2025), $6.7 billion (Q3 2025), and $6.8 billion (Q2 2025).